The University of Melbourne, Department of Medicine (Austin Health), Heidelberg, VIC, Australia.
Lancet Diabetes Endocrinol. 2014 Dec;2(12):954-62. doi: 10.1016/S2213-8587(14)70200-1.
Guidelines recommend gradual weight loss for the treatment of obesity, indicative of a widely held opinion that weight lost rapidly is more quickly regained. We aimed to investigate the effect of the rate of weight loss on the rate of regain in obese people.
For this two phase, randomised, non-masked, dietary intervention trial in a Melbourne metropolitan hospital, we enrolled 204 participants (51 men and 153 women) aged 18–70 years with a BMI between 30 and 45 kg/m2. During phase 1, we randomly assigned (1:1) participants with a block design (block sizes of 2, 4, and 6) to account for sex, age, and BMI, to either a 12-week rapid weight loss or a 36-week gradual programme, both aimed at 15% weight loss. We placed participants who lost 12·5% or more weight during phase 1 on a weight maintenance diet for 144 weeks (phase 2). The primary outcome was mean weight loss maintained at week 144 of phase 2. We investigated the primary outcome by both completers only and intention-to-treat analyses. This study is registered with the Australian New Zealand Clinical Trials Registry, number ACTRN12611000190909.
200 participants were randomly assigned to the gradual weight loss (n=103) or rapid weight loss (n=97) programme between Aug 8, 2008, and March 9, 2010. After phase 1, 51 (50%) participants in the gradual weight loss group and 76 (81%) in the rapid weight loss group achieved 12·5% or more weight loss in the allocated time and started phase 2. At the end of phase 2, both gradual weight loss and rapid weight loss participants who completed the study (n=43 in gradual weight loss and n=61 in rapid weight loss) had regained most of their lost weight (gradual weight loss 71·2% regain, 95% CI 58·1–84·3 vs rapid weight loss 70·5%, 57·8–83·2). Intention-to-treat analysis showed similar results (gradual weight loss 76·3% regain, 95% CI 65·2–87·4 vs rapid weight loss 76·3%, 65·8–86·8). In phase 1, one participant in the rapid weight loss group developed cholecystitis, requiring cholecystectomy. In phase 2, two participants in the rapid weight loss group developed cancer.
The rate of weight loss does not affect the proportion of weight regained within 144 weeks. These findings are not consistent with present dietary guidelines which recommend gradual over rapid weight loss, based on the belief that rapid weight loss is more quickly regained.
The Australian National Health and Medical Research Council and the Sir Edward Dunlop Medical Research Foundation.
指南建议逐渐减轻体重以治疗肥胖症,这表明人们普遍认为快速减轻的体重会更快地反弹。我们旨在研究体重减轻率对肥胖者体重反弹率的影响。
在墨尔本大都市医院进行的这项两阶段、随机、非盲、饮食干预试验中,我们招募了 204 名参与者(51 名男性和 153 名女性),年龄在 18 至 70 岁之间,BMI 为 30 至 45 kg/m2。在第一阶段,我们采用 1:1 随机分组(按性别、年龄和 BMI 分组,块大小为 2、4 和 6),将参与者随机分配到 12 周快速减重或 36 周缓慢减重方案,目标均为减重 15%。将在第一阶段体重减轻 12.5%或更多的参与者置于体重维持饮食中 144 周(第二阶段)。主要结局是第二阶段第 144 周的平均体重减轻。我们仅通过完成者和意向治疗分析来研究主要结局。该研究在澳大利亚和新西兰临床试验注册中心注册,编号为 ACTRN12611000190909。
200 名参与者于 2008 年 8 月 8 日至 2010 年 3 月 9 日之间被随机分配到缓慢减重(n=103)或快速减重(n=97)组。在第一阶段后,51 名(50%)缓慢减重组和 76 名(81%)快速减重组的参与者在分配的时间内达到了 12.5%或更多的体重减轻,并开始了第二阶段。在第二阶段结束时,完成研究的缓慢减重和快速减重参与者(分别为 43 名和 61 名)都恢复了大部分体重(缓慢减重组 71.2%的体重恢复,95%CI 58.1-84.3 与快速减重组 70.5%,57.8-83.2)。意向治疗分析显示出类似的结果(缓慢减重组 76.3%的体重恢复,95%CI 65.2-87.4 与快速减重组 76.3%,65.8-86.8)。在第一阶段,快速减重组的一名参与者出现了胆囊炎,需要进行胆囊切除术。在第二阶段,快速减重组的两名参与者被诊断出患有癌症。
体重减轻率并不影响 144 周内体重恢复的比例。这些发现与目前的饮食指南不一致,这些指南建议逐渐减轻体重而不是快速减轻体重,基于快速减轻体重更容易反弹的观点。
澳大利亚国家健康与医学研究委员会和爱德华·邓禄普医学研究基金会。